Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.

@article{Lundholm2010EffectsBD,
  title={Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.},
  author={Kent G Lundholm and Lena Gunnebo and Ulla B. Koerner and B M Iresj{\"o} and Cecilia Engstr{\"o}m and Anders G. Hyltander and Ulrika Smedh and Ingvar Bosaeus},
  journal={Cancer},
  year={2010},
  volume={116 8},
  pages={2044-52}
}
BACKGROUND The short-term provision of ghrelin to patients with cancer indicates that there may be benefits from long-term provision of ghrelin for the palliative treatment of weight-losing cancer patients. This hypothesis was evaluated in a randomized, double-blind, phase 2 study. METHODS Weight-losing cancer patients with solid gastrointestinal tumors were randomized to receive either high-dose ghrelin treatment (13 microg/kg daily; n = 17 patients) or low-dose ghrelin treatment (0.7 microg… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

Similar Papers

Loading similar papers…